Introduction – Company Background

GuangXin Industrial Co., Ltd. is a specialized manufacturer dedicated to the development and production of high-quality insoles.

With a strong foundation in material science and footwear ergonomics, we serve as a trusted partner for global brands seeking reliable insole solutions that combine comfort, functionality, and design.

With years of experience in insole production and OEM/ODM services, GuangXin has successfully supported a wide range of clients across various industries—including sportswear, health & wellness, orthopedic care, and daily footwear.

From initial prototyping to mass production, we provide comprehensive support tailored to each client’s market and application needs.

At GuangXin, we are committed to quality, innovation, and sustainable development. Every insole we produce reflects our dedication to precision craftsmanship, forward-thinking design, and ESG-driven practices.

By integrating eco-friendly materials, clean production processes, and responsible sourcing, we help our partners meet both market demand and environmental goals.

Core Strengths in Insole Manufacturing

At GuangXin Industrial, our core strength lies in our deep expertise and versatility in insole and pillow manufacturing. We specialize in working with a wide range of materials, including PU (polyurethane), natural latex, and advanced graphene composites, to develop insoles and pillows that meet diverse performance, comfort, and health-support needs.

Whether it's cushioning, support, breathability, or antibacterial function, we tailor material selection to the exact requirements of each project-whether for foot wellness or ergonomic sleep products.

We provide end-to-end manufacturing capabilities under one roof—covering every stage from material sourcing and foaming, to precision molding, lamination, cutting, sewing, and strict quality control. This full-process control not only ensures product consistency and durability, but also allows for faster lead times and better customization flexibility.

With our flexible production capacity, we accommodate both small batch custom orders and high-volume mass production with equal efficiency. Whether you're a startup launching your first insole or pillow line, or a global brand scaling up to meet market demand, GuangXin is equipped to deliver reliable OEM/ODM solutions that grow with your business.

Customization & OEM/ODM Flexibility

GuangXin offers exceptional flexibility in customization and OEM/ODM services, empowering our partners to create insole products that truly align with their brand identity and target market. We develop insoles tailored to specific foot shapes, end-user needs, and regional market preferences, ensuring optimal fit and functionality.

Our team supports comprehensive branding solutions, including logo printing, custom packaging, and product integration support for marketing campaigns. Whether you're launching a new product line or upgrading an existing one, we help your vision come to life with attention to detail and consistent brand presentation.

With fast prototyping services and efficient lead times, GuangXin helps reduce your time-to-market and respond quickly to evolving trends or seasonal demands. From concept to final production, we offer agile support that keeps you ahead of the competition.

Quality Assurance & Certifications

Quality is at the heart of everything we do. GuangXin implements a rigorous quality control system at every stage of production—ensuring that each insole meets the highest standards of consistency, comfort, and durability.

We provide a variety of in-house and third-party testing options, including antibacterial performance, odor control, durability testing, and eco-safety verification, to meet the specific needs of our clients and markets.

Our products are fully compliant with international safety and environmental standards, such as REACH, RoHS, and other applicable export regulations. This ensures seamless entry into global markets while supporting your ESG and product safety commitments.

ESG-Oriented Sustainable Production

At GuangXin Industrial, we are committed to integrating ESG (Environmental, Social, and Governance) values into every step of our manufacturing process. We actively pursue eco-conscious practices by utilizing eco-friendly materials and adopting low-carbon production methods to reduce environmental impact.

To support circular economy goals, we offer recycled and upcycled material options, including innovative applications such as recycled glass and repurposed LCD panel glass. These materials are processed using advanced techniques to retain performance while reducing waste—contributing to a more sustainable supply chain.

We also work closely with our partners to support their ESG compliance and sustainability reporting needs, providing documentation, traceability, and material data upon request. Whether you're aiming to meet corporate sustainability targets or align with global green regulations, GuangXin is your trusted manufacturing ally in building a better, greener future.

Let’s Build Your Next Insole Success Together

Looking for a reliable insole manufacturing partner that understands customization, quality, and flexibility? GuangXin Industrial Co., Ltd. specializes in high-performance insole production, offering tailored solutions for brands across the globe. Whether you're launching a new insole collection or expanding your existing product line, we provide OEM/ODM services built around your unique design and performance goals.

From small-batch custom orders to full-scale mass production, our flexible insole manufacturing capabilities adapt to your business needs. With expertise in PU, latex, and graphene insole materials, we turn ideas into functional, comfortable, and market-ready insoles that deliver value.

Contact us today to discuss your next insole project. Let GuangXin help you create custom insoles that stand out, perform better, and reflect your brand’s commitment to comfort, quality, and sustainability.

🔗 Learn more or get in touch:
🌐 Website: https://www.deryou-tw.com/
📧 Email: shela.a9119@msa.hinet.net
📘 Facebook: facebook.com/deryou.tw
📷 Instagram: instagram.com/deryou.tw

Graphene-infused pillow ODM Indonesia

Are you looking for a trusted and experienced manufacturing partner that can bring your comfort-focused product ideas to life? GuangXin Industrial Co., Ltd. is your ideal OEM/ODM supplier, specializing in insole production, pillow manufacturing, and advanced graphene product design.

With decades of experience in insole OEM/ODM, we provide full-service manufacturing—from PU and latex to cutting-edge graphene-infused insoles—customized to meet your performance, support, and breathability requirements. Our production process is vertically integrated, covering everything from material sourcing and foaming to molding, cutting, and strict quality control.Graphene-infused pillow ODM Thailand

Beyond insoles, GuangXin also offers pillow OEM/ODM services with a focus on ergonomic comfort and functional innovation. Whether you need memory foam, latex, or smart material integration for neck and sleep support, we deliver tailor-made solutions that reflect your brand’s values.

We are especially proud to lead the way in ESG-driven insole development. Through the use of recycled materials—such as repurposed LCD glass—and low-carbon production processes, we help our partners meet sustainability goals without compromising product quality. Our ESG insole solutions are designed not only for comfort but also for compliance with global environmental standards.Cushion insole OEM solution China

At GuangXin, we don’t just manufacture products—we create long-term value for your brand. Whether you're developing your first product line or scaling up globally, our flexible production capabilities and collaborative approach will help you go further, faster.Orthopedic pillow OEM solutions China

📩 Contact us today to learn how our insole OEM, pillow ODM, and graphene product design services can elevate your product offering—while aligning with the sustainability expectations of modern consumers.Insole ODM factory in Taiwan

Researchers have sequenced the white oak genome, revealing crucial insights into its genetic diversity, disease resistance, and evolutionary history. A recent study details the genome of the highly prized white oak. The white oak (Quercus alba) is a keystone species in eastern North American forests, valued for its economic, ecological, and cultural significance. Despite its abundance, the species is experiencing a decline in seedling recruitment across much of its range. In a study published in New Phytologist, researchers from the University of Tennessee Institute of Agriculture, Indiana University, the University of Kentucky, the U.S. Forest Service, and other institutions have mapped the species’ complex genome for the first time. Their findings offer new insights into plant evolution, tree breeding, and genetic improvement, providing valuable information for forest management and conservation efforts. Lead authors Meg Staton, an associate professor of bioinformatics and computational genomics at the University of Tennessee, and Drew Larson, a National Science Foundation postdoctoral fellow at Indiana University, collaborated with scientists from academia, the U.S. Forest Service, state forests, and industry to collect and analyze genetic sequence data representative of white oak populations. White oaks are among the target species for the UT Tree Improvement Program, which has been working for decades to improve tree genetics. Scott Schlarbaum, UTIA distinguished professor of forestry, leads the UT Tree Improvement Program and is among the co-authors of the paper describing the white oak genome and how local adaptations may have implications for the species to heat and drought stress. Credit: Photo by A. Mains, courtesy UTIA Also central to the effort were Seth DeBolt, professor of horticulture and director of the James B. Beam Institute for Kentucky Spirits at the University of Kentucky, and Dana Nelson of the U.S. Forest Service Southern Research Station and director of the Forest Health Research and Education Center at the University of Kentucky. Genetic Diversity and Evolutionary Insights Says Staton and her co-authors in the paper, “The white oak genome represents a major new resource for studying genome diversity and evolution in Quercus. Also, unbiased gene annotation is key to accurately assessing R [disease resistance] gene evolution in Quercus.” The paper addresses the extent of the genetic diversity and population differentiation in Q. alba, and how gene content and disease resistance genes appear to have evolved during the history of Quercus and related taxa. The authors also discuss phylogenetic hypotheses – how oak species are evolutionarily related – as supported by whole genome data. The study notes that the amount of standing genetic variation and the extent to which populations are locally adapted will have implications for the response of Q. alba and other white oak species to increasingly prevalent heat and drought stress. The details of this study are of interest to those invested in the sustainability of white oak across economic, ecological, and cultural boundaries. Reference: “A haplotype-resolved reference genome of Quercus alba sheds light on the evolutionary history of oaks” by Drew A. Larson, Margaret E. Staton, Beant Kapoor, Nurul Islam-Faridi, Tetyana Zhebentyayeva, Shenghua Fan, Jozsef Stork, Austin Thomas, Alaa S. Ahmed, Elizabeth C. Stanton, Allan Houston, Scott E. Schlarbaum, Matthew W. Hahn, John E. Carlson, Albert G. Abbott, Seth DeBolt and C. Dana Nelson, 11 February 2025, New Phytologist. DOI: 10.1111/nph.20463 Part of the project was sponsored by Makers Mark Distillery and Independent Stave Company. The white oak tree whose genome was sequenced for the study is from the Makers Mark campus in Loretto, Kentucky.

Odontoblasts containing the ion channel TRPC5 (green) tightly pack the area between the pulp and the dentin in a mouse’s molar. The cells’ long-haired extensions fill the thin canals in dentin that extend towards the enamel. Credit: L. Bernal et al./Science Advances 2021 Researchers have identified TRPC5, a protein in tooth cells, as the sensor behind cold sensitivity in decayed teeth. Blocking this protein, as clove oil does, may offer new ways to treat tooth pain. For people with tooth decay, drinking a cold beverage can be agony. “It’s a unique kind of pain,” says David Clapham, vice president and chief scientific officer of the Howard Hughes Medical Institute (HHMI). “It’s just excruciating.” Now, he and an international team of scientists have figured out how teeth sense the cold and pinpointed the molecular and cellular players involved. In both mice and humans, tooth cells called odontoblasts contain cold-sensitive proteins that detect temperature drops, the team reports March 26, 2021, in the journal Science Advances. Signals from these cells can ultimately trigger a jolt of pain to the brain. The work offers an explanation for how one age-old home remedy eases toothaches. The main ingredient in clove oil, which has been used for centuries in dentistry, contains a chemical that blocks the “cold sensor” protein, says electrophysiologist Katharina Zimmermann, who led the work at Friedrich-Alexander University Erlangen-Nürnberg in Germany. Developing drugs that target this sensor even more specifically could potentially eliminate tooth sensitivity to cold, Zimmermann says. “Once you have a molecule to target, there is a possibility of treatment.” Mystery Channel Teeth decay when films of bacteria and acid eat away at the enamel, the hard, whitish covering of teeth. As enamel erodes, pits called cavities form. Roughly 2.4 billion people — about a third of the world’s population — have untreated cavities in permanent teeth, which can cause intense pain, including extreme cold sensitivity. No one really knew how teeth sensed the cold, though scientists had proposed one main theory. Tiny canals inside the teeth contain fluid that moves when the temperature changes. Somehow, nerves can sense the direction of this movement, which signals whether a tooth is hot or cold, some researchers have suggested. “We can’t rule this theory out,” but there wasn’t any direct evidence for it, says Clapham a neurobiologist at HHMI’s Janelia Research Campus. Fluid movement in teeth — and tooth biology in general — is difficult to study. Scientists have to cut through the enamel — the hardest substance in the human body — and another tough layer called dentin, all without pulverizing the tooth’s soft pulp and the blood vessels and nerves within it. Sometimes, the whole tooth “will just fall to pieces,” Zimmermann says. Zimmerman, Clapham, and their colleagues didn’t set out to study teeth. Their work focused primarily on ion channels, pores in cells’ membranes that act like molecular gates. After detecting a signal — a chemical message or temperature change, for example — the channels either clamp shut or open wide and let ions flood into the cell. This creates an electrical pulse that zips from cell to cell. It’s a rapid way to send information, and crucial in the brain, heart, and other tissues. About fifteen years ago, when Zimmermann was a postdoc in Clapham’s lab, the team discovered that an ion channel called TRPC5 was highly sensitive to the cold. But the team didn’t know where in the body TRPC5’s cold-sensing ability came into play. It wasn’t the skin, they found. Mice that lacked the ion channel could still sense the cold, the team reported in 2011 in the journal Proceedings of the National Academy of Sciences. After that, “we hit a dead end,” Zimmermann says. The team was sitting at lunch one day discussing the problem when the idea finally hit. “David said, ‘Well, what other tissues in the body sense the cold?’ Zimmermann recalls. The answer was teeth. The Whole Tooth TRPC5 does reside in teeth — and more so in teeth with cavities, study coauthor Jochen Lennerz, a pathologist from Massachusetts General Hospital, discovered after examining specimens from human adults. A novel experimental set up in mice convinced the researchers that TRPC5 indeed functions as a cold sensor. Instead of cracking a tooth open and solely examining its cells in a dish, Zimmermann’s team looked at the whole system: jawbone, teeth, and tooth nerves. The team recorded neural activity as an ice-cold solution touched the tooth. In normal mice, this frigid dip sparked nerve activity, indicating the tooth was sensing the cold. Not so in mice lacking TRPC5 or in teeth treated with a chemical that blocked the ion channel. That was a key clue that the ion channel could detect cold, Zimmermann says. One other ion channel the team studied, TRPA1, also seemed to play a role. The team traced TRPC5’s location to a specific cell type, the odontoblast, that resides between the pulp and the dentin. When someone with a dentin-exposed tooth bites down on a popsicle, for example, those TRPC5-packed cells pick up on the cold sensation and an “ow!” signal speeds to the brain. That sharp sensation hasn’t been as extensively studied as other areas of science, Clapham says. Tooth pain may not be considered a trendy subject, he says, “but it is important and it affects a lot of people.” Zimmermann points out that the team’s journey towards this discovery spanned more than a decade. Figuring out the function of particular molecules and cells is difficult, she says. “And good research can take a long time.” Reference: “Odontoblast TRPC5 channels signal cold pain in teeth” by Laura Bernal, Pamela Sotelo-Hitschfeld, Christine König, Viktor Sinica, Amanda Wyatt, Zoltan Winter, Alexander Hein, Filip Touska, Susanne Reinhardt, Aaron Tragl, Ricardo Kusuda, Philipp Wartenberg, Allen Sclaroff, John D. Pfeifer, Fabien Ectors, Andreas Dahl, Marc Freichel, Viktorie Vlachova, Sebastian Brauchi, Carolina Roza, Ulrich Boehm, David E. Clapham, Jochen K. Lennerz and Katharina Zimmermann, 26 March 2021, Science Advances. DOI: 10.1126/sciadv.abf5567

Scientists discovered a potential candidate for antibiotic drug development in a soil bacterium known as Lentzea flaviverrucosa. Discovery from soil bacterium could lead to potent new cancer treatments, showcasing the therapeutic potential of rare microbes. As drug-resistant and emerging infections become an increasingly serious global health threat, demand for new types of antibiotics is surging. Researchers are racing to reexamine a group of microbes known as actinomycetes, which are one of our most successful sources of therapeutics. Scientists at Washington University in St. Louis and the University of Hawaii discovered a potential candidate for antibiotic drug development from one such microbe, the soil bacterium known as Lentzea flaviverrucosa. They reported their findings in a study published the week of April 11 in the journal Proceedings of the National Academy of Sciences. Rare Actinomycetes in Drug Discovery “Rare actinomycetes are an underexploited source of new bioactive compounds,” said Joshua Blodgett, assistant professor of biology in Arts & Sciences, co-corresponding author of the new study. “Our genomics-based approach allowed us to identify an unusual peptide for future drug design efforts.” Joshua Blodgett, Assistant Professor of Biology, Washington University in St. Louis. Credit: Sean Garcia, Washington University Actinomycetes produce bioactive components that form the basis for many clinically useful drugs, especially antibiotics and anticancer agents. Since the 1940s, pharmaceutical companies have analyzed many common actinomycetes to see what they might produce. Today, about two-thirds of all antibiotics used in hospitals and clinics are derived in part from actinomycetes. But some of these microbes — known as the rare actinomycetes — have been cataloged but not extensively studied so far. The definition of “rare” is not set in stone, but these actinomycetes tend to be more difficult to find in nature than others, and they may grow more slowly, Blodgett said. For these and other reasons, many rare actinomycetes have not been fully characterized for drug discovery and biotechnology purposes. Among the rare actinomycetes, Lentzea flaviverrucosa emerged as a standout, Blodgett said. “It has unusual biology, encoding for unusual enzymology, driving the production of unexpected chemistry, all harbored within a largely overlooked group of bacteria,” he said. Discovery of Bioactive Molecules Against Cancer Blodgett and his collaborators, including co-corresponding author Shugeng Cao at the University of Hawaii, discovered that this rare actinomycete produces molecules that are active against certain types of human ovarian cancer, fibrosarcoma, prostate cancer, and leukemia cell lines. The scientists initially spotted Lentzea flaviverrucosa when they went looking for rare actinomycetes with a genetic hallmark that indicates that they can make piperazyl molecules. These molecules incorporate an unusual building block that is a flag for potential drug-like activities, Blodgett said. But as the researchers dug deeper, they uncovered a few other surprises. “At a high level, it looked as if one region of the genome might be able to make two different molecules. That’s just a little strange,” Blodgett said. “Usually we think of a gene cluster, groups of genes that are like blueprints for making individual drug-like molecules. But it looked like there was almost too much chemistry predicted within this single cluster.” The early clues proved to be accurate. Using a combination of modern metabolomics with chemical and structural biology techniques, Blodgett and team were able to show that this rare actinomycete actually produces two different bioactive molecules from a single set of genes called a supercluster. Supercluster: A Rare Phenomenon in Biology Superclusters are scarce in biology. This particular kind of supercluster encodes for two different molecules that are later welded together in an atypical chemical reaction. “Nature is welding two different things together,” Blodgett said. “And, as it turns out, against several different cancer cell lines, when you stick A and B together, it turns into something more potent.” Reference: “Discovery of unusual dimeric piperazyl cyclopeptides encoded by a Lentzea flaviverrucosa DSM 44664 biosynthetic supercluster” by Chunshun Li, Yifei Hu, Xiaohua Wu, Spencer D. Stumpf, Yunci Qi, John M. D’Alessandro, Keshav K. Nepal, Ariel M. Sarotti, Shugeng Cao and Joshua A. V. Blodgett, 11 April 2022, Proceedings of the National Academy of Sciences. DOI: 10.1073/pnas.2117941119

DVDV1551RTWW78V